Globus Medical Total Current Assets 2010-2024 | GMED

Globus Medical total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Globus Medical total current assets for the quarter ending September 30, 2024 were $2.057B, a 7.26% increase year-over-year.
  • Globus Medical total current assets for 2023 were $1.915B, a 94.78% increase from 2022.
  • Globus Medical total current assets for 2022 were $0.983B, a 13.75% increase from 2021.
  • Globus Medical total current assets for 2021 were $0.865B, a 5.2% increase from 2020.
Globus Medical Annual Total Current Assets
(Millions of US $)
2023 $1,915
2022 $983
2021 $865
2020 $822
2019 $687
2018 $631
2017 $620
2016 $514
2015 $545
2014 $470
2013 $417
2012 $360
2011 $259
2010 $219
2009 $
Globus Medical Quarterly Total Current Assets
(Millions of US $)
2024-09-30 $2,057
2024-06-30 $1,924
2024-03-31 $1,829
2023-12-31 $1,915
2023-09-30 $1,917
2023-06-30 $1,210
2023-03-31 $1,070
2022-12-31 $983
2022-09-30 $920
2022-06-30 $891
2022-03-31 $917
2021-12-31 $865
2021-09-30 $981
2021-06-30 $892
2021-03-31 $814
2020-12-31 $822
2020-09-30 $812
2020-06-30 $697
2020-03-31 $642
2019-12-31 $687
2019-09-30 $637
2019-06-30 $584
2019-03-31 $618
2018-12-31 $631
2018-09-30 $646
2018-06-30 $633
2018-03-31 $615
2017-12-31 $620
2017-09-30 $564
2017-06-30 $535
2017-03-31 $541
2016-12-31 $514
2016-09-30 $478
2016-06-30 $535
2016-03-31 $515
2015-12-31 $545
2015-09-30 $506
2015-06-30 $455
2015-03-31 $456
2014-12-31 $470
2014-09-30 $485
2014-06-30 $467
2014-03-31 $461
2013-12-31 $417
2013-09-30 $385
2013-06-30 $338
2013-03-31 $323
2012-12-31 $360
2012-09-30 $333
2012-06-30 $294
2012-03-31 $283
2011-12-31 $259
2011-09-30
2011-06-30
2011-03-31
2010-12-31 $219
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.364B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.066B 26.11
Intuitive Surgical (ISRG) United States $211.086B 110.36
Alcon (ALC) Switzerland $41.615B 27.84
Edwards Lifesciences (EW) United States $41.156B 26.14
IQVIA Holdings (IQV) United States $35.821B 19.74
IDEXX Laboratories (IDXX) United States $34.331B 40.43
DexCom (DXCM) United States $32.958B 49.63
Waters (WAT) United States $23.988B 35.47
STERIS (STE) Ireland $20.691B 23.82
SONOVA HOLDING (SONVY) Switzerland $19.710B 0.00
Hologic (HOLX) United States $15.740B 17.09
Fresenius Medical Care AG KGaA (FMS) Germany $13.538B 13.90
Sysmex ADR (SSMXY) Japan $11.726B 0.00
Penumbra (PEN) United States $10.120B 99.13
Masimo (MASI) United States $9.225B 44.63
Glaukos (GKOS) United States $8.623B 0.00
Teleflex (TFX) United States $8.419B 13.43
Integer Holdings (ITGR) United States $4.729B 26.81
Inari Medical (NARI) United States $4.657B 0.00
PROCEPT BioRobotics (PRCT) United States $3.967B 0.00
Veracyte (VCYT) United States $3.145B 94.37
Nihon Kohden (NHNKY) Japan $2.658B 20.19
LivaNova (LIVN) United Kingdom $2.623B 15.14
Tandem Diabetes Care (TNDM) United States $2.309B 0.00
Elekta AB (EKTAY) Sweden $2.167B 19.48
TransMedics (TMDX) United States $1.920B 60.85
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
Alphatec Holdings (ATEC) United States $1.641B 0.00
Artivion (AORT) United States $1.288B 85.33
RxSight (RXST) United States $1.225B 0.00
Pulse Biosciences (PLSE) United States $1.083B 0.00
OPKO Health (OPK) United States $1.003B 0.00
Paragon 28 (FNA) United States $0.911B 0.00
AxoGen (AXGN) United States $0.796B 0.00
Mesa Laboratories (MLAB) United States $0.758B 17.88
IRadimed (IRMD) United States $0.750B 40.53
AVANOS MEDICAL, INC (AVNS) United States $0.732B 12.44
SiBone (SIBN) United States $0.700B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.693B 0.00
OrthoPediatrics (KIDS) United States $0.658B 0.00
Semler Scientific (SMLR) United States $0.599B 31.55
Treace Medical Concepts (TMCI) United States $0.543B 0.00
AngioDynamics (ANGO) United States $0.503B 0.00
Delcath Systems (DCTH) United States $0.458B 0.00
Pacific Biosciences Of California (PACB) United States $0.449B 0.00
CVRx (CVRX) United States $0.428B 0.00
Tactile Systems Technology (TCMD) United States $0.418B 22.60
ClearPoint Neuro (CLPT) United States $0.415B 0.00
NeuroPace (NPCE) United States $0.357B 0.00
Alpha Tau Medical (DRTS) Israel $0.273B 0.00
Inogen (INGN) United States $0.249B 0.00
Accuray (ARAY) United States $0.225B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.171B 0.00
Sight Sciences (SGHT) United States $0.144B 0.00
Sensus Healthcare (SRTS) United States $0.108B 11.51
Atossa Genetics (ATOS) United States $0.104B 0.00
908 Devices (MASS) United States $0.104B 0.00
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Vicarious Surgical (RBOT) United States $0.094B 0.00
Monogram Orthopaedics (MGRM) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
Neuronetics (STIM) United States $0.075B 0.00
WORK Medical Technology Group (WOK) China $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
InspireMD (NSPR) Israel $0.071B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.93
Baird Medical Investment Holdings (BDMD) $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Microbot Medical (MBOT) United States $0.033B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.027B 0.00
NexGel (NXGL) United States $0.024B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Aspira Women's Health (AWH) United States $0.008B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00